Abstract
Glycogen storage disease type 1 (GSD1) is an inherited disorder caused by impaired glucose 6-phosphatase activity. This impairment translates into the inhibition of endogenous glucose production an...
Highlights
Glycogen storage disease type 1 (GSD1) is a rare genetic disease, due to an impairment in glucose 6-phosphatase (G6Pase)[1,2] activity
This study showed that AMPK activity was impaired, while mammalian target of rapamycin (mTOR) was activated, translating in decreased autophagy (Figure 1)
carbohydrate responsive element-binding protein (ChREBP) and mTOR activation and AMPK inhibition likely represent key molecular events that orchestrate metabolic reprogramming in GSD1
Summary
Glycogen storage disease type 1 (GSD1) is a rare genetic disease, due to an impairment in glucose 6-phosphatase (G6Pase)[1,2] activity.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Inborn Errors of Metabolism and Screening
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
